Thresholds of risk factors for ischemic stroke in type 2 diabetic patients with and without albuminuria-A non-linear approach

Clinical Neurology and Neurosurgery

Volumn 110, Issue 7, 2008, Pages 701-709

  Yang, Xilin ^a   So, Wing Yee ^a   Ma, Ronald C ^a   Ko, Gary T ^a   Kong, Alice P ^a   Ho, Chung Shun ^a   Lam, Christopher W ^a   Ozaki, Risa ^a   Cockram, Clive S ^a   Tong, Peter C ^a   Wong, Vivian ^b   Chan, Juliana C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Albuminuria; Ischemic stroke; Restricted Cubic Spline; Risk factors; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHINESE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; ALBUMINURIA; BODY MASS INDEX; BRAIN ISCHEMIA; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STROKE;

EID: 46949106592     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.04.010     Document Type: Article

References (36)

1. Manson J., Colditz G., Stampfer M., Willett W.C., Krolewski A.S., Rosner B., et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151 (1991) 1141-1147
2. Almdal T., Scharling H., Jensen J.S., and Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 164 (2004) 1422-1426
3. Takeya Y., Popper J.S., Shimizu Y., Kato H., Rhoads G.G., and Kagan A. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke 15 (1984) 15-23
4. Tanne D., Yaari S., and Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation 98 (1998) 1365-1371
5. He J., Klag M.J., Wu Z., and Whelton P.K. Stroke in the People's Republic of China II. Meta-analysis of hypertension and risk of stroke. Stroke 26 (1995) 2228-2232
6. Yang X.L., So W.Y., Kong A.P., Clarke P., Ho C.S., Lam C.W., et al. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetologia 49 (2006) 2299-2308
7. Falkstedt D., Hemmingsson T., Rasmussen F., and Lundberg I. Body mass index in late adolescence and its association with coronary heart disease and stroke in middle age among Swedish men. Int J Obes 31 (2006) 777-783
8. Tseng C.H., Chong C.K., Sheu J.J., Wu T.H., and Tseng C.P. Prevalence and risk factors for stroke in type 2 diabetic patients in Taiwan: a cross-sectional survey of a national sample by telephone interview. Diabet Med 22 (2005) 477-482
9. Davis T.M., Millns H., Stratton I.M., Holman R.R., and Turner R.C. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med 159 (1999) 1097-1103
10. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
11. Chan W.B., Chan N.N., Lai C.W., So W.Y., Lo M.K., Lee K.F., et al. Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney Int 70 (2006) 711-716
12. Cederholm J., Eliasson B., Nilsson P.M., Weiss L., and Gudbjornsdottir S. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 67 (2005) 258-266
13. Shankar A., Klein R., Moss S.E., Klein B.E., and Wong T.Y. The relationship between albuminuria and hypercholesterolemia. J Nephrol 17 (2004) 658-665
14. Tong P.C., Lee K.F., So W.Y., Ng M.H., Chan W.B., Lo M.K., et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27 (2004) 216-222
15. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2937-2944
16. Mogensen C.E., Vestbo E., Poulsen P.L., Christiansen C., Damsgaard E.M., Eiskjaer H., et al. Microalbuminuria and potential confounders A review and some observations on variability of urinary albumin excretion. Diabetes Care 18 (1995) 572-581
17. Harrell F. Regression modelling strategies with applications to linear models, logistic regression and survival analysis (2001), Spinger-Varlag New York, Inc., New York
18. So W.Y., Yang X.L., Ma R.C., Kong P.S., Lam C.W., Ho C.S., et al. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 24 (2007) 238-246
19. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
20. Lin D.Y., Wei L.J., and Ying Z. Checking the COX model with cumulative sums of martingale-based residuals. Biometrika 80 (1993) 557-572
21. Chudek J., and Wiecek A. Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep 58 Suppl. (2006) 81-88
22. Ni Mhurchu C., Rodgers A., Pan W.H., Gu D.F., and Woodward M. Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310,000 participants. Int J Epidemiol 33 (2004) 751-758
23. Ravid M., Brosh D., Ravid-Safran D., Levy Z., and Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158 (1998) 998-1004
24. Tong P.C., Kong A.P., So W.Y., Ng M.H., Yang X., Ng M.C., et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes. Diabetes Care 29 (2006) 2439-2444
25. Vlagopoulos P.T., Tighiouart H., Weiner D.E., Griffith J., Pettitt D., Salem D.N., et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 16 (2005) 3403-3410
26. Liu L., Wang J.G., Gong L., Liu G., and Staessen J.A. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 16 Pt 1 (1998) 1823-1829
27. Wang J.G., Staessen J.A., Gong L., and Liu L. Chinese trial on isolated systolic hypertension in the elderly Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 160 (2000) 211-220
28. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004) 421-431
29. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
30. American Diabetes Association. Clinical practice recommendations. Diabetes Care Suppl. 1 (2005) S1-S79
31. Keech A., Simes R.J., Barter P., Best J., Scott R., Taskinen M.R., et al. FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 (2005) 1849-1861
32. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
33. Shahar E., Chambless L.E., Rosamond W.D., Boland L.L., Ballantyne C.M., McGovern P.G., et al. Atherosclerosis Risk in Communities Study Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 34 (2003) 623-631
34. Wanner C., Krane V., Marz W., Olschewski M., Mann J.F., Ruf G., et al. German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
35. Dormandy J.A., Charbonnel B., Eckland D.J., Erdmann E., Massi-Benedetti M., Moules I.K., et al. PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
36. Amarenco P., Bogousslavsky J., Callahan III A., Goldstein L.B., Hennerici M., Rudolph A.E., et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559